Sodium hyaluronate eyedrops in the treatment of dry eyes

Shigeto Shimmura, Masafumi Ono, Kazumi Shinozaki, Ikuko Toda, Etsuko Takamura, Yukihiko Mashima, Kazuo Tsubota

Research output: Contribution to journalArticle

141 Citations (Scopus)

Abstract

Background-Several studies in the past have attempted to demonstrate the efficacy of sodium hyaluronate in the treatment of dry eyes. However, results have been conflicting and a definite conclusion has not yet been reached. This study recruited a larger group of patients and has incorporated for the first time both fluorescein and rose bengal staining in the evaluation of the epithelium. Methods-Eighteen albino rabbit corneas were used in a basic animal study to demonstrate the efficacy of sodium hyaluronate by comparing the effects on the rate of epithelial healing. The optimal concentration to be used in the clinical trial was determined from the results of the basic study. In the clinical study 104 patients with dry eye syndrome were enrolled in a double masked controlled clinical trial. Patients received sodium hyaluronate drops in one eye and control medication in the other eye for 4 weeks. Grading of subjective symptoms and clinical examinations were performed at 2 and 4 weeks. Results-In the animal study sodium hyaluronate at concentrations of 0.1% and 0.5% significantly accelerated the recovery time of iodine vapour induced corneal erosions (p< 0.01). In the clinical study no statistical significance was observed in the improvement ofsubjective symptoms or rose bengal staining, while fluorescein scores significantly improved in eyes receiving sodium hyaluronate (p=0.0001) at 4 weeks. Conclusion-Sodium hyaluronate drops applied in six daily doses could not be demonstrated to offer advantages over conventional tear supplies in the improvement of subjective symptoms, but may play a role in maintaining a healthy corneal epithelium.

Original languageEnglish
Pages (from-to)1007-1011
Number of pages5
JournalBritish Journal of Ophthalmology
Volume79
Issue number11
DOIs
Publication statusPublished - 1995

Fingerprint

Ophthalmic Solutions
Hyaluronic Acid
Rose Bengal
Fluorescein
Therapeutics
Dry Eye Syndromes
Staining and Labeling
Corneal Epithelium
Controlled Clinical Trials
Tears
Iodine
Cornea
Epithelium
Clinical Trials
Rabbits

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine
  • Emergency Medicine
  • Ophthalmology

Cite this

Sodium hyaluronate eyedrops in the treatment of dry eyes. / Shimmura, Shigeto; Ono, Masafumi; Shinozaki, Kazumi; Toda, Ikuko; Takamura, Etsuko; Mashima, Yukihiko; Tsubota, Kazuo.

In: British Journal of Ophthalmology, Vol. 79, No. 11, 1995, p. 1007-1011.

Research output: Contribution to journalArticle

Shimmura, S, Ono, M, Shinozaki, K, Toda, I, Takamura, E, Mashima, Y & Tsubota, K 1995, 'Sodium hyaluronate eyedrops in the treatment of dry eyes', British Journal of Ophthalmology, vol. 79, no. 11, pp. 1007-1011. https://doi.org/10.1136/bjo.79.11.1007
Shimmura, Shigeto ; Ono, Masafumi ; Shinozaki, Kazumi ; Toda, Ikuko ; Takamura, Etsuko ; Mashima, Yukihiko ; Tsubota, Kazuo. / Sodium hyaluronate eyedrops in the treatment of dry eyes. In: British Journal of Ophthalmology. 1995 ; Vol. 79, No. 11. pp. 1007-1011.
@article{b2123ca7a4a54e068b1d24ed17cbe304,
title = "Sodium hyaluronate eyedrops in the treatment of dry eyes",
abstract = "Background-Several studies in the past have attempted to demonstrate the efficacy of sodium hyaluronate in the treatment of dry eyes. However, results have been conflicting and a definite conclusion has not yet been reached. This study recruited a larger group of patients and has incorporated for the first time both fluorescein and rose bengal staining in the evaluation of the epithelium. Methods-Eighteen albino rabbit corneas were used in a basic animal study to demonstrate the efficacy of sodium hyaluronate by comparing the effects on the rate of epithelial healing. The optimal concentration to be used in the clinical trial was determined from the results of the basic study. In the clinical study 104 patients with dry eye syndrome were enrolled in a double masked controlled clinical trial. Patients received sodium hyaluronate drops in one eye and control medication in the other eye for 4 weeks. Grading of subjective symptoms and clinical examinations were performed at 2 and 4 weeks. Results-In the animal study sodium hyaluronate at concentrations of 0.1{\%} and 0.5{\%} significantly accelerated the recovery time of iodine vapour induced corneal erosions (p< 0.01). In the clinical study no statistical significance was observed in the improvement ofsubjective symptoms or rose bengal staining, while fluorescein scores significantly improved in eyes receiving sodium hyaluronate (p=0.0001) at 4 weeks. Conclusion-Sodium hyaluronate drops applied in six daily doses could not be demonstrated to offer advantages over conventional tear supplies in the improvement of subjective symptoms, but may play a role in maintaining a healthy corneal epithelium.",
author = "Shigeto Shimmura and Masafumi Ono and Kazumi Shinozaki and Ikuko Toda and Etsuko Takamura and Yukihiko Mashima and Kazuo Tsubota",
year = "1995",
doi = "10.1136/bjo.79.11.1007",
language = "English",
volume = "79",
pages = "1007--1011",
journal = "British Journal of Ophthalmology",
issn = "0007-1161",
publisher = "BMJ Publishing Group",
number = "11",

}

TY - JOUR

T1 - Sodium hyaluronate eyedrops in the treatment of dry eyes

AU - Shimmura, Shigeto

AU - Ono, Masafumi

AU - Shinozaki, Kazumi

AU - Toda, Ikuko

AU - Takamura, Etsuko

AU - Mashima, Yukihiko

AU - Tsubota, Kazuo

PY - 1995

Y1 - 1995

N2 - Background-Several studies in the past have attempted to demonstrate the efficacy of sodium hyaluronate in the treatment of dry eyes. However, results have been conflicting and a definite conclusion has not yet been reached. This study recruited a larger group of patients and has incorporated for the first time both fluorescein and rose bengal staining in the evaluation of the epithelium. Methods-Eighteen albino rabbit corneas were used in a basic animal study to demonstrate the efficacy of sodium hyaluronate by comparing the effects on the rate of epithelial healing. The optimal concentration to be used in the clinical trial was determined from the results of the basic study. In the clinical study 104 patients with dry eye syndrome were enrolled in a double masked controlled clinical trial. Patients received sodium hyaluronate drops in one eye and control medication in the other eye for 4 weeks. Grading of subjective symptoms and clinical examinations were performed at 2 and 4 weeks. Results-In the animal study sodium hyaluronate at concentrations of 0.1% and 0.5% significantly accelerated the recovery time of iodine vapour induced corneal erosions (p< 0.01). In the clinical study no statistical significance was observed in the improvement ofsubjective symptoms or rose bengal staining, while fluorescein scores significantly improved in eyes receiving sodium hyaluronate (p=0.0001) at 4 weeks. Conclusion-Sodium hyaluronate drops applied in six daily doses could not be demonstrated to offer advantages over conventional tear supplies in the improvement of subjective symptoms, but may play a role in maintaining a healthy corneal epithelium.

AB - Background-Several studies in the past have attempted to demonstrate the efficacy of sodium hyaluronate in the treatment of dry eyes. However, results have been conflicting and a definite conclusion has not yet been reached. This study recruited a larger group of patients and has incorporated for the first time both fluorescein and rose bengal staining in the evaluation of the epithelium. Methods-Eighteen albino rabbit corneas were used in a basic animal study to demonstrate the efficacy of sodium hyaluronate by comparing the effects on the rate of epithelial healing. The optimal concentration to be used in the clinical trial was determined from the results of the basic study. In the clinical study 104 patients with dry eye syndrome were enrolled in a double masked controlled clinical trial. Patients received sodium hyaluronate drops in one eye and control medication in the other eye for 4 weeks. Grading of subjective symptoms and clinical examinations were performed at 2 and 4 weeks. Results-In the animal study sodium hyaluronate at concentrations of 0.1% and 0.5% significantly accelerated the recovery time of iodine vapour induced corneal erosions (p< 0.01). In the clinical study no statistical significance was observed in the improvement ofsubjective symptoms or rose bengal staining, while fluorescein scores significantly improved in eyes receiving sodium hyaluronate (p=0.0001) at 4 weeks. Conclusion-Sodium hyaluronate drops applied in six daily doses could not be demonstrated to offer advantages over conventional tear supplies in the improvement of subjective symptoms, but may play a role in maintaining a healthy corneal epithelium.

UR - http://www.scopus.com/inward/record.url?scp=0028846985&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028846985&partnerID=8YFLogxK

U2 - 10.1136/bjo.79.11.1007

DO - 10.1136/bjo.79.11.1007

M3 - Article

VL - 79

SP - 1007

EP - 1011

JO - British Journal of Ophthalmology

JF - British Journal of Ophthalmology

SN - 0007-1161

IS - 11

ER -